The Yield Lab — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing.
AgTechBiotechHealthtechChampaign, US
Aaron Gilbertie(CEO)Federico Zuckermann(Executive Officer, Director)
BoardRobert Easter(Director)Paul Olivo(Director)Gary Durack(Director)
Co-investorsMissouri Technology CorporationArsenalCultivation CapitalIllinois VenturesThe Yield Lab Asia Pacific
NanobOx develops nanobubble technology based on a patented electric field method for use in agriculture, aquaculture, and other biological applications.
AgTechCleantechDeep TechHardwareIdaho Falls, US
John Favier(Co-founder & CEO)inMohammad Reza Ghaani(Co-founder & CTO)Michael Andrus(Executive Officer, Director)Joe Turner(Director)Tyler Flint(Executive Officer, Director)
Co-investorsEnterprise IrelandThe Yield Lab Europe
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.